A. Clinton Allen, Director at PSYCHEMEDICS CORP (PMD), bought 2,000 shares at $3.99 ($8K) on 2020-11-13, disclosed to the SEC on 2020-11-13.
Open-market purchase of $8k PMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| CLCT | SELL | 2018-04-11 | $177K | — | Filing → |
| CLCT | SELL | 2018-02-26 | $974K | — | Filing → |
| LKQ | SELL | 2017-08-29 | $543K | — | Filing → |